Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

95.74
Delayed Data
As of Feb 10
 +1.85 / +1.97%
Today’s Change
90.00
Today|||52-Week Range
314.88
-35.90%
Year-to-Date

Today’s Trading

Previous close93.89
Today’s open95.18
Day’s range95.00 - 102.97
Volume880,477
Average volume (3 months)575,377
Market cap$2.3B
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+32.98%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book8.71

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.26-0.80%
MYGNMyriad Genetics Inc+0.03+0.09%
ACADACADIA Pharmaceutica...-0.25-1.35%
MDCOMedicines Co-0.53-1.79%
Data as of 02/10/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$3.17
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

Partner Offers